| Jonathon Scott Cline, MD | |
|
1000 E Main St, Danville, IN 46122-1948 | |
| (317) 745-4451 | |
| (317) 718-6740 |
| Full Name | Jonathon Scott Cline |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 17 Years |
| Location | 1000 E Main St, Danville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396903902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 01066475A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Care Hospice Services, Llc | Indianapolis, IN | Hospice |
| Hendricks Regional Health | Danville, IN | Hospital |
| Danville Regional Rehabilitation | Danville, IN | Nursing home |
| Countryside Meadows | Avon, IN | Nursing home |
| Brownsburg Meadows | Brownsburg, IN | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hendricks County Hospital | 4880505528 | 274 |
News Archive
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
Huron debuts its new ‘Scan Index Search' platform, connecting pathologists, researchers and educators with the expertise of their colleagues.
There is safety in numbers. That's one of the key findings of a study published today in CMAJ Open that found a child's risk of death or injury in a residential fire was greatly reduced in neighbourhoods with larger than average households.
"Government representatives are meeting in Geneva this week to decide whether to introduce a global ban on mercury that could include thiomersal, a mercury-based preservative that has been used in some vaccine manufacturing since the 1930s to prevent bacterial or fungal contamination of multidose vials of vaccine," Seth Berkley, a medical epidemiologist and chief executive of the GAVI Alliance, writes in a New York Times opinion piece.
› Verified 6 days ago
| Entity Name | State Of Indiana Auditor Of State |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700876224 PECOS PAC ID: 1759280118 Enrollment ID: O20040105000564 |
News Archive
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
Huron debuts its new ‘Scan Index Search' platform, connecting pathologists, researchers and educators with the expertise of their colleagues.
There is safety in numbers. That's one of the key findings of a study published today in CMAJ Open that found a child's risk of death or injury in a residential fire was greatly reduced in neighbourhoods with larger than average households.
"Government representatives are meeting in Geneva this week to decide whether to introduce a global ban on mercury that could include thiomersal, a mercury-based preservative that has been used in some vaccine manufacturing since the 1930s to prevent bacterial or fungal contamination of multidose vials of vaccine," Seth Berkley, a medical epidemiologist and chief executive of the GAVI Alliance, writes in a New York Times opinion piece.
› Verified 6 days ago
| Entity Name | Hendricks County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063411551 PECOS PAC ID: 4880505528 Enrollment ID: O20040811000309 |
News Archive
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
Huron debuts its new ‘Scan Index Search' platform, connecting pathologists, researchers and educators with the expertise of their colleagues.
There is safety in numbers. That's one of the key findings of a study published today in CMAJ Open that found a child's risk of death or injury in a residential fire was greatly reduced in neighbourhoods with larger than average households.
"Government representatives are meeting in Geneva this week to decide whether to introduce a global ban on mercury that could include thiomersal, a mercury-based preservative that has been used in some vaccine manufacturing since the 1930s to prevent bacterial or fungal contamination of multidose vials of vaccine," Seth Berkley, a medical epidemiologist and chief executive of the GAVI Alliance, writes in a New York Times opinion piece.
› Verified 6 days ago
| Entity Name | Arm Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992131049 PECOS PAC ID: 8729214887 Enrollment ID: O20131119000908 |
News Archive
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
Huron debuts its new ‘Scan Index Search' platform, connecting pathologists, researchers and educators with the expertise of their colleagues.
There is safety in numbers. That's one of the key findings of a study published today in CMAJ Open that found a child's risk of death or injury in a residential fire was greatly reduced in neighbourhoods with larger than average households.
"Government representatives are meeting in Geneva this week to decide whether to introduce a global ban on mercury that could include thiomersal, a mercury-based preservative that has been used in some vaccine manufacturing since the 1930s to prevent bacterial or fungal contamination of multidose vials of vaccine," Seth Berkley, a medical epidemiologist and chief executive of the GAVI Alliance, writes in a New York Times opinion piece.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathon Scott Cline, MD 1100 Southfield Dr, Suite 1370, Plainfield, IN 46168-4498 Ph: (317) 837-5571 | Jonathon Scott Cline, MD 1000 E Main St, Danville, IN 46122-1948 Ph: (317) 745-4451 |
News Archive
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
UT Southwestern Medical Center and the Universidad Peruana Cayetano Heredia in Peru have signed a five-year affiliation agreement that establishes an exchange program for medical students and related educational opportunities.
Huron debuts its new ‘Scan Index Search' platform, connecting pathologists, researchers and educators with the expertise of their colleagues.
There is safety in numbers. That's one of the key findings of a study published today in CMAJ Open that found a child's risk of death or injury in a residential fire was greatly reduced in neighbourhoods with larger than average households.
"Government representatives are meeting in Geneva this week to decide whether to introduce a global ban on mercury that could include thiomersal, a mercury-based preservative that has been used in some vaccine manufacturing since the 1930s to prevent bacterial or fungal contamination of multidose vials of vaccine," Seth Berkley, a medical epidemiologist and chief executive of the GAVI Alliance, writes in a New York Times opinion piece.
› Verified 6 days ago
Dr. Rick A Robertson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 202 Myers Rd, Danville, IN 46122 Phone: 317-718-8436 Fax: 317-718-8438 | |
Dr. Douglas Mark Mulinix, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 202 Myers Rd, Danville, IN 46122 Phone: 317-718-8436 Fax: 317-718-8438 | |
Jesse Z Li, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ln, Suite 225, Danville, IN 46122 Phone: 317-718-4730 Fax: 317-718-4733 | |
G. Joseph Herr, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ln, Suite 225, Danville, IN 46122 Phone: 317-718-4730 Fax: 317-718-4733 |